These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7387671)

  • 1. (Des-histidine 1) (N epsilon-phenylthiocarbamoyllysine 12)-glucagon: effects on glycogenolysis in perfused rat liver.
    Khan BA; Bregman MD; Nugent CA; Hruby VJ; Brendel K
    Biochem Biophys Res Commun; 1980 Apr; 93(3):729-36. PubMed ID: 7387671
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of glucagon and catecholamine effects on isolated sheep hepatocytes.
    Morand C; Yacoub C; Remesy C; Demigne C
    Am J Physiol; 1988 Oct; 255(4 Pt 2):R539-46. PubMed ID: 2459977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic glucagon derivatives for structure-function studies.
    Hruby VJ; Wright DE; Lin MC; Rodbell M
    Metabolism; 1976 Nov; 25(11 Suppl 1):1323-5. PubMed ID: 185491
    [No Abstract]   [Full Text] [Related]  

  • 4. Nalpha-trinitrophenyl glucagon: an inhibitor of glucagon-stimulated cyclic AMP production and its effects on glycogenolysis.
    Cote TE; Epand RM
    Biochim Biophys Acta; 1979 Jan; 582(2):295-306. PubMed ID: 216418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of glucagon effects by changes in extracellular pH and calcium.
    Morand C; Remesy C; Demigne C
    Biochim Biophys Acta; 1988 Feb; 968(2):192-202. PubMed ID: 2829979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic activity and conformational properties of glucagon and glucagon analogs.
    Epand RM; Cote TE; Hoa DH; Rosselin G; Schreier S
    Metabolism; 1976 Nov; 25(11 Suppl 1):1317-8. PubMed ID: 185490
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nonsteroidal anti-inflammatory drugs on glycogenolysis in isolated hepatocytes.
    Brass EP; Garrity MJ
    Br J Pharmacol; 1985 Oct; 86(2):491-6. PubMed ID: 3863682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 effects on cyclic AMP and glycogen metabolism in rat liver.
    Sweat FW; Yamashita L
    Biochem Biophys Res Commun; 1978 Jun; 82(3):879-86. PubMed ID: 212029
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by insulin and glucagon of the activation of glycogenolysis by perivascular nerve stimulation in the perfused rat liver.
    Beckh K; Hartmann H; Jungermann K
    FEBS Lett; 1982 Sep; 146(1):69-72. PubMed ID: 6754444
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid hormone stimulation of glucose and urea production in isolated liver cells.
    Moxley MA; Bell NH; Wagle SR; Allen DO; Ashmore J
    Am J Physiol; 1974 Nov; 227(5):1058-61. PubMed ID: 4374088
    [No Abstract]   [Full Text] [Related]  

  • 13. Epinephrine-and glucagon-sensitive adenylate cyclases of rat liver during aging. Evidence for membrane instability associated with increased enzymatic activity.
    Kalish MI; Katz MS; Piñeyro MA; Gregerman RI
    Biochim Biophys Acta; 1977 Aug; 483(2):452-66. PubMed ID: 889839
    [No Abstract]   [Full Text] [Related]  

  • 14. Two types of hormone-responsive adenylate cyclase in the rat liver.
    Yamatani K; Sato N; Wada K; Suda K; Wakasugi K; Ogawa A; Takahashi K; Sasaki H; Hara M
    Biochim Biophys Acta; 1987 Nov; 931(2):180-7. PubMed ID: 2444265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of somatostatin-14 and somatostatin-28 on glucagon-induced glycogenolysis from the perfused rat liver.
    Seno M; Seino Y; Taminato T; Tsuda K; Kitano N; Takeda J; Fukumoto H; Koh G; Imura H
    Metabolism; 1988 Jun; 37(6):587-90. PubMed ID: 2897614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization.
    Coolican SA; Jones BN; England RD; Flanders KC; Condit JD; Gurd RS
    Biochemistry; 1982 Sep; 21(20):4974-81. PubMed ID: 7138842
    [No Abstract]   [Full Text] [Related]  

  • 17. The stimulation of rat liver adenylate cyclase by prostaglandins E1 and E2.
    Yamashita L; Sweat FW
    Biochem Biophys Res Commun; 1976 May; 70(2):438-44. PubMed ID: 938500
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of enzyme activity by glucagon: increased hormonal activity of iodinated glucagon.
    Fuller RW; Bromer WW; Snoddy HD; Baker JC
    Adv Enzyme Regul; 1975; 13():201-15. PubMed ID: 1975
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins.
    Brass EP; Garrity MJ; Robertson RP
    FEBS Lett; 1984 Apr; 169(2):293-6. PubMed ID: 6585308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and isolation of a glucagon antagonist.
    Bregman MD; Hruby VJ
    FEBS Lett; 1979 May; 101(1):191-4. PubMed ID: 446735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.